Answers are grounded in this paper and cite their sources.
Analysis shows increased radiotherapy for stage I lung cancer during COVID-19, indicating alignment with ESMO guidelines.
The pandemic led to a significant increase in radiotherapy for Stage I NSCLC, aligning with prevailing ESMO guidelines. However, this shift persisted post-pandemic when surgical capacity was restored. Short-term outcomes were unchanged.
No takes yet. Share an insight, caveat, or question.
Vuren et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: